​

Establishment Labs (ESTA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ESTA Stock Forecast

Establishment Labs (ESTA) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $78.00, with a high of $110.00 and a low of $45.00. This represents a 148.01% increase from the last price of $31.45.

$25 $42 $59 $76 $93 $110 High: $110 Avg: $78 Low: $45 Last Closed Price: $31.45

ESTA Stock Rating

Establishment Labs stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (83.33%), 2 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 2 10 0 Strong Sell Sell Hold Buy Strong Buy

ESTA Price Target Upside V Benchmarks

TypeNameUpside
StockEstablishment Labs148.01%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$57.50
Last Closing Price$31.45$31.45$31.45
Upside/Downside--82.83%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25151--7
Mar, 25141--6
Feb, 25151--7
Jan, 25151--7
Dec, 24151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 22, 2024Joanne WuenschCitigroup$45.00$44.052.16%43.08%
Jun 06, 2024Anthony PetroneMizuho Securities$70.00$53.8929.89%122.58%
Apr 01, 2024Anthony PetroneMizuho Securities$65.00$50.9027.70%106.68%
Dec 28, 2022Stephens$87.00$60.4543.92%176.63%
Apr 22, 2022BTIG$110.00$81.8934.33%249.76%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024Cowen & Co.BuyBuyhold
Oct 01, 2024StephensNeutralNeutralhold
Aug 22, 2024CitigroupUnderperformUnderperformhold
Aug 22, 2024CitigroupNeutralNeutralhold
Jul 10, 2024CitigroupNeutralNeutralhold
May 22, 2024Cowen & Co.BuyBuyhold
May 22, 2024CitigroupBuyNeutraldowngrade
Apr 15, 2024BTIGBuyBuyhold
Apr 03, 2024CitigroupBuyBuyhold
Apr 01, 2024StephensBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.63$-1.72$-3.08$-3.07$-3.03----
Avg Forecast$-1.56$-1.42$-3.21$-3.17$-2.42$-1.81$-1.11$0.75$2.00
High Forecast$-1.50$-1.37$-3.15$-3.14$-2.23$-1.72$-0.72$0.76$2.02
Low Forecast$-1.59$-1.46$-3.24$-3.19$-2.53$-1.95$-1.85$0.73$1.95
Surprise %4.49%21.13%-4.05%-3.15%25.21%----

Revenue Forecast

$50M $150M $250M $350M $450M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$84.68M$126.68M$161.70M$165.15M$166.03M----
Avg Forecast$82.92M$126.30M$160.94M$164.94M$165.97M$206.54M$261.49M$389.80M$519.60M
High Forecast$84.39M$128.55M$162.24M$165.11M$167.16M$207.63M$261.49M$392.60M$523.33M
Low Forecast$80.57M$122.73M$158.44M$164.70M$162.91M$205.46M$261.49M$382.61M$510.02M
Surprise %2.12%0.30%0.47%0.13%0.03%----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-38.12M$-41.14M$-75.21M$-78.50M$-84.60M----
Avg Forecast$-39.83M$-36.45M$-82.20M$-81.09M$-61.03M$-47.04M$-31.69M$19.06M$51.20M
High Forecast$-38.36M$-35.11M$-80.54M$-80.45M$-57.18M$-44.06M$-18.37M$19.38M$51.68M
Low Forecast$-40.75M$-37.29M$-83.06M$-81.72M$-64.87M$-50.02M$-47.43M$18.74M$49.97M
Surprise %-4.29%12.88%-8.50%-3.19%38.62%----

ESTA Forecast FAQ

Is Establishment Labs stock a buy?

Establishment Labs stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Establishment Labs is a favorable investment for most analysts.

What is Establishment Labs's price target?

Establishment Labs's price target, set by 12 Wall Street analysts, averages $78 over the next 12 months. The price target range spans from $45 at the low end to $110 at the high end, suggesting a potential 148.01% change from the previous closing price of $31.45.

How does Establishment Labs stock forecast compare to its benchmarks?

Establishment Labs's stock forecast shows a 148.01% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for Establishment Labs over the past three months?

  • April 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Establishment Labs’s EPS forecast?

Establishment Labs's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.81, marking a -40.26% decrease from the reported $-3.03 in 2024. Estimates for the following years are $-1.11 in 2026, $0.75 in 2027, and $2 in 2028.

What is Establishment Labs’s revenue forecast?

Establishment Labs's average annual revenue forecast for its fiscal year ending in December 2025 is $206.54M, reflecting a 24.41% increase from the reported $166.02M in 2024. The forecast for 2026 is $261.49M, followed by $389.8M for 2027, and $519.6M for 2028.

What is Establishment Labs’s net income forecast?

Establishment Labs's net income forecast for the fiscal year ending in December 2025 stands at $-47.042M, representing a -44.39% decrease from the reported $-84.596M in 2024. Projections indicate $-31.688M in 2026, $19.06M in 2027, and $51.2M in 2028.